95 related articles for article (PubMed ID: 11410302)
1. The design and evaluation of a phantom for the audit of the treatment chain for prostate radiotherapy.
Perrin BA; Jordan TJ; Hounsell AR
Radiother Oncol; 2001 Jul; 60(1):37-43. PubMed ID: 11410302
[TBL] [Abstract][Full Text] [Related]
2. A solid water pelvic and prostate phantom for imaging, volume rendering, treatment planning, and dosimetry for an RTOG multi-institutional, 3-D dose escalation study. Radiation Therapy Oncology Group.
Paliwal BR; Ritter MA; McNutt TR; Mackie TR; Thomadsen BR; Purdy JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):205-11. PubMed ID: 9747839
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.
McDermott LN; Wendling M; van Asselen B; Stroom J; Sonke JJ; van Herk M; Mijnheer BJ
Med Phys; 2006 Oct; 33(10):3921-30. PubMed ID: 17089854
[TBL] [Abstract][Full Text] [Related]
4. Planning, computer optimization, and dosimetric verification of a segmented irradiation technique for prostate cancer.
Damen EM; Brugmans MJ; van der Horst A; Bos L; Lebesque JV; Mijnheer BJ; McShan DL; Fraass BA; Kessler ML
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1183-95. PubMed ID: 11240262
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric intercomparison for multicenter clinical trials using a patient-based anatomic pelvic phantom.
Ebert MA; Harrison KM; Howlett SJ; Cornes D; Bulsara M; Hamilton CS; Kron T; Joseph DJ; Denham JW
Med Phys; 2011 Sep; 38(9):5167-75. PubMed ID: 21978061
[TBL] [Abstract][Full Text] [Related]
6. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.
Chen L; Price RA; Wang L; Li J; Qin L; McNeeley S; Ma CM; Freedman GM; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):636-47. PubMed ID: 15380601
[TBL] [Abstract][Full Text] [Related]
7. Potential benefits of dosimetric VMAT tracking verified with 3D film measurements.
Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
Med Phys; 2016 May; 43(5):2162. PubMed ID: 27147328
[TBL] [Abstract][Full Text] [Related]
8. Design, manufacture, and evaluation of an anthropomorphic pelvic phantom purpose-built for radiotherapy dosimetric intercomparison.
Harrison KM; Ebert MA; Kron T; Howlett SJ; Cornes D; Hamilton CS; Denham JW
Med Phys; 2011 Oct; 38(10):5330-7. PubMed ID: 21992351
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric intercomparison for two Australasian clinical trials using an anthropomorphic phantom.
Kron T; Hamilton C; Roff M; Denham J
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):566-79. PubMed ID: 11872306
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a composite Gel-Alanine phantom on an end-to-end test to treat multiple brain metastases by a single isocenter VMAT technique.
Pavoni JF; Neves-Junior WFP; da Silveira MA; Haddad CMK; Baffa O
Med Phys; 2017 Sep; 44(9):4869-4879. PubMed ID: 28594461
[TBL] [Abstract][Full Text] [Related]
11. A 2D ion chamber array audit of wedged and asymmetric fields in an inhomogeneous lung phantom.
Lye J; Kenny J; Lehmann J; Dunn L; Kron T; Alves A; Cole A; Williams I
Med Phys; 2014 Oct; 41(10):101712. PubMed ID: 25281951
[TBL] [Abstract][Full Text] [Related]
12. Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
Lavely WC; Scarfone C; Cevikalp H; Li R; Byrne DW; Cmelak AJ; Dawant B; Price RR; Hallahan DE; Fitzpatrick JM
Med Phys; 2004 May; 31(5):1083-92. PubMed ID: 15191296
[TBL] [Abstract][Full Text] [Related]
13. A versatile phantom for quality assurance in the UK Medical Research Council (MRC) RT01 trial (ISRCTN47772397) in conformal radiotherapy for prostate cancer.
Moore AR; Warrington AP; Aird EG; Bidmead AM; Dearnaley DP
Radiother Oncol; 2006 Jul; 80(1):82-5. PubMed ID: 16828908
[TBL] [Abstract][Full Text] [Related]
14. Design and implementation of a water phantom for IMRT, arc therapy, and tomotherapy dose distribution measurements.
Pallotta S; Marrazzo L; Bucciolini M
Med Phys; 2007 Oct; 34(10):3724-31. PubMed ID: 17985617
[TBL] [Abstract][Full Text] [Related]
15. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer.
Yan D; Lockman D; Brabbins D; Tyburski L; Martinez A
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):289-302. PubMed ID: 10925000
[TBL] [Abstract][Full Text] [Related]
16. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
[TBL] [Abstract][Full Text] [Related]
17. DEMAT: A multi-institutional dosimetry audit of rotational and static intensity-modulated radiotherapy.
Lafond C; Chiavassa S; Bertaut C; Boussion N; Chapel N; Chapron L; Coste F; Crespin S; Dy G; Faye PA; Leleu C; Bouvier J; Madec L; Mesgouez J; Palisson J; Vela A; Delpon G
Phys Med; 2016 May; 32(5):664-70. PubMed ID: 27132030
[TBL] [Abstract][Full Text] [Related]
18. Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy.
Bauman G; Gete E; Chen JZ; Wong E
Med Dosim; 2004; 29(1):18-25. PubMed ID: 15023389
[TBL] [Abstract][Full Text] [Related]
19. Development of a dedicated phantom for multi-target single-isocentre stereotactic radiosurgery end to end testing.
Poder J; Brown R; Porter H; Gupta R; Ralston A
J Appl Clin Med Phys; 2018 Nov; 19(6):99-108. PubMed ID: 30221462
[TBL] [Abstract][Full Text] [Related]
20. Remote dosimetric auditing of clinical trials: The need for vendor specific models to convert images to dose.
Miri N; Vial P; Greer PB
J Appl Clin Med Phys; 2019 Jan; 20(1):175-183. PubMed ID: 30597730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
